publications
10 July
The cancer–natural killer cell immunity cycle
17 March
You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
21 August
Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response
30 July
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
12 May
Quantifying NK cell growth and survival changes in response to cytokines and regulatory checkpoint blockade helps identify optimal culture and expansion conditions
23 January
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
24 May
Molecular insight into targeting the NK cell immune response to cancer
24 September
The life and death of immune cell types: the role of BCL-2 anti-apoptotic molecules
18 September
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
24 February
IL-15 signaling in NK cell cancer immunotherapy